spacer
spacer

PDBsum entry 4a1v

Go to PDB code: 
protein metals Protein-protein interface(s) links
Hydrolase/peptide PDB id
4a1v

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
190 a.a.
16 a.a.
17 a.a.
Metals
__K
_CL ×3
Waters ×80
PDB id:
4a1v
Name: Hydrolase/peptide
Title: Co-complex structure of ns3-4a protease with the optimized inhibitory peptide cp5-46a-4d5e
Structure: Non-structural protein 4a, serine protease ns3. Chain: a, b. Fragment: residues 1678-1690,1028-1206. Synonym: ns4a, p8, hepacivirin, ns3p, p70. Engineered: yes. Other_details: fusion protein of 4a (1678-1690) with ns3 (1028-1206). Cp5-46a-4d5e. Chain: c, d. Engineered: yes.
Source: Hepatitis c virus subtype 1b. Organism_taxid: 31647. Expressed in: escherichia coli. Expression_system_taxid: 469008. Expression_system_variant: rosetta2. Other_details: hcv replicon i389/ns3-3'utr (aj242654). Synthetic: yes. Synthetic construct. Organism_taxid: 32630
Resolution:
2.20Å     R-factor:   0.188     R-free:   0.239
Authors: S.Schmelz,J.Kuegler,J.Collins,D.W.Heinz
Key ref: J.Kügler et al. (2012). High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants. J Biol Chem, 287, 39224-39232. PubMed id: 22965230
Date:
20-Sep-11     Release date:   19-Sep-12    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P26662  (POLG_HCVJA) -  Genome polyprotein from Hepatitis C virus genotype 1b (isolate Japanese)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
3010 a.a.
190 a.a.*
Protein chain
No UniProt id for this chain
Struc: 16 a.a.
Protein chain
No UniProt id for this chain
Struc: 17 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 18 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 2: Chains A, B: E.C.2.7.7.48  - RNA-directed Rna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
RNA(n)
+ ribonucleoside 5'-triphosphate
= RNA(n+1)
+ diphosphate
   Enzyme class 3: Chains A, B: E.C.3.4.21.98  - hepacivirin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1'.
   Enzyme class 4: Chains A, B: E.C.3.4.22.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 5: Chains A, B: E.C.3.6.1.15  - nucleoside-triphosphate phosphatase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
ribonucleoside 5'-triphosphate
+ H2O
= ribonucleoside 5'-diphosphate
+ phosphate
+ H(+)
   Enzyme class 6: Chains A, B: E.C.3.6.4.13  - Rna helicase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + H2O = ADP + phosphate + H+
ATP
+ H2O
= ADP
+ phosphate
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
J Biol Chem 287:39224-39232 (2012)
PubMed id: 22965230  
 
 
High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants.
J.Kügler, S.Schmelz, J.Gentzsch, S.Haid, E.Pollmann, J.van den Heuvel, R.Franke, T.Pietschmann, D.W.Heinz, J.Collins.
 
  ABSTRACT  
 
Hepatitis C virus (HCV) NS3-4A protease is essential for viral replication. All current small molecular weight drugs against NS3-4A are substrate peptidomimetics that have a similar binding and resistance profile. We developed inhibitory peptides (IPs) capping the active site and binding via a novel "tyrosine" finger at an alternative NS3-4A site that is of particular interest for further HCV drug development. The peptides are not cleaved due to a combination of geometrical constraints and impairment of the oxyanion hole function. Selection and optimization through combinatorial phagemid display, protein crystallography, and further modifications resulted in a 32-amino acid peptide with a K(i) of 0.53 nm. Inhibition of viral replication in cell culture was demonstrated by fusion to a cell-penetrating peptide. Negligible susceptibility to known (A156V and R155K) resistance mutations of the NS3-4A protease was observed. This work shows for the first time that antiviral peptides can target an intracellular site and reveals a novel druggable site on the HCV protease.
 

 

spacer

spacer